23 Feb Opsis Therapeutics

Posted at 19:27h in by brady

David Gamm, M.D., Ph.D., Chief Science Officer and Co-Founder

Madison, WI

(Private)

Virtual Presentation

Opsis Therapeutics was founded in 2016 as a joint venture with FUJIFILM. We are developing advanced treatments for patients suffering from inherited retinal disease and age-related macular degeneration. Our team developed methods to manufacture authentic human photoreceptors that offer potential for dramatic improvement in the standard of care for patients suffering from permanent vision loss. Recently, our success in developing, scale-up, and manufacture of human photoreceptors resulted in a partnership with BlueRock Therapeutics.

www.opsistx.com

About the Event

The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures. Tackling the commercialization hurdles facing the cell and gene therapy sector today, this meeting covers a wide range of topics from clinical trial design to alternative payment models to scale-up and supply chain platforms for advanced therapies. The program features expert-led panels, extensive partnering capabilities, exclusive networking opportunities, and 100+ dedicated presentations by the leading publicly traded and privately held companies in the space. Attracting over 1,200 attendees – over 20% of which are C-level executives – this conference enables key partnerships through more than 3,000 one-on-one meetings while highlighting the significant clinical and commercial progress in the field.

Dates & Location

October 11-13, 2022
Carlsbad, CA

Program Organizer

By using this website you agree to accept our Privacy Policy and Terms & Conditions